Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
4,78 USD | +2,14 % | -1,85 % | -59,34 % |
Resumen de negocios
Número de empleados: 5 055
Ventas por actividad
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
EVT Execute
65,8
%
| 547 | 72,8 % | 515 | 65,8 % | -5,89 % |
EVT Innovate
34,2
%
| 205 | 27,2 % | 267 | 34,2 % | +30,36 % |
Ventas por región
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
59,5
%
| 418 | 55,7 % | 459 | 59,5 % | +9,83 % |
Rest of the World
12,3
%
| 127 | 16,9 % | 95 | 12,3 % | -24,91 % |
United Kingdom
11,2
%
| 115 | 15,3 % | 86 | 11,2 % | -25,06 % |
Switzerland
8,4
%
| - | - | 65 | 8,4 % | - |
Germany
4,4
%
| 59 | 7,8 % | 34 | 4,4 % | -42,04 % |
France
4,1
%
| 32 | 4,3 % | 32 | 4,1 % | -0,83 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 07/02/23 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 01/05/12 |
Cord Dohrmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/10 |
Gabriele Hansen
IRO | Public Communications Contact | - | - |
Volker Braun
IRC | Investor Relations Contact | - | - |
Matthias Evers
PRN | Corporate Officer/Principal | 51 | 01/05/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Roland Sackers
BRD | Director/Board Member | 56 | 19/06/19 |
Chairman | 63 | 17/06/14 | |
Elaine Sullivan
BRD | Director/Board Member | 63 | 09/06/15 |
Director/Board Member | 41 | 22/06/22 | |
Director/Board Member | 62 | 01/06/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 177 542 097 | 160 931 634 ( 90,64 %) | 249 915 ( 0,1408 %) | 90,64 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
EXSCIENTIA PLC 11.86% | 14 035 200 | 11.86% | 56 000 448 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. |
Miscellaneous Commercial Services
|
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. |
Miscellaneous Commercial Services
|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. |
Miscellaneous Commercial Services
|
Aptuit (Verona) Srl
Aptuit (Verona) Srl Pharmaceuticals: MajorHealth Technology Aptuit (Verona) Srl engages in the provision of integrated drug development solutions. It offers Indigo and Indigo-Select. The company was founded in 2004 and is headquartered in Verona, Italy. |
Pharmaceuticals: Major
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+46,73 % | 54,63 mil M | |
-4,54 % | 39,92 mil M | |
+37,23 % | 38,82 mil M | |
+16,40 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-21,14 % | 18,78 mil M | |
+26,34 % | 12,21 mil M | |
+1,54 % | 12,16 mil M | |
+27,55 % | 11,94 mil M |
- Bolsa de valores
- Acciones
- Acción EVT
- Acción EVO
- Empresa Evotec SE